AAPG
Ascentage Pharma Takes Strides in Global Hematology Oncology Expansion
Leading global hematology oncology company, Ascentage Pharma, has made significant strides in advancing its strategic objectives during the first half of 2026. The company's recent conference call provided insights into its progress, which we'll delve into below. As reported on the company's unaudited financial